Related Experiment Videos
Does nicotinic acid (niacin) lower blood pressure?
1Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY40213, USA. hbaysmd@aol.com
International Journal of Clinical Practice
|December 5, 2008
Summary
Nicotinic acid (niacin) may lower blood pressure (BP), a key cardiovascular disease risk factor. Research suggests both acute and chronic BP reduction, though further studies are needed to confirm mechanisms.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Nicotinic acid (niacin) is a primary treatment for dyslipidemia, a significant cardiovascular disease (CVD) risk factor.
- Blood pressure (BP) is another critical CVD risk factor, and niacin's potential BP-lowering effects warrant investigation.
Purpose of the Study:
- To review available data on the effects of nicotinic acid (niacin) on blood pressure (BP).
- To explore potential mechanisms behind niacin's impact on BP.
Main Methods:
- Review of existing literature and clinical trial data on niacin's effects on BP.
- Analysis of acute and chronic administration effects.
- Examination of data related to laropiprant and prostaglandin D2 (PGD2) interactions.
Main Results:
- Acute niacin administration may cause vasodilation and lower BP.
- Some studies suggest a chronic, dose-dependent BP-lowering effect of niacin.
- Laropiprant does not inhibit niacin's BP-lowering effects, suggesting the mechanism is not DP1 receptor-mediated vasodilation.
Conclusions:
- Niacin exhibits potential for both acute and chronic blood pressure reduction.
- The mechanism for chronic BP lowering by niacin is likely independent of dermal vasodilation via DP1 receptor activation.
- Further research is necessary to fully elucidate the extent and mechanisms of niacin's BP-lowering effects.
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...